Jason Bablak
Director de Operaciones en Attune Pharmaceuticals, Inc. .
Perfil
Jason Bablak is currently the Chief Operating Officer at Attune Pharmaceuticals, Inc. He previously worked as the Director of Regulatory Affairs at Plasma Protein Therapeutics Association from 1997 to 2000, as an Attorney at Popham Haik, Schnobrich & Kaufman Ltd.
from 1993 to 1995, as the Vice President of Public Policy & Legal Affairs at Immune Deficiency Foundation from 2000 to 2003, as the Vice President of Regulatory Affairs at Thar Pharmaceuticals, Inc., as the Vice President of Regulatory Affairs & Product Development at Lev Pharmaceuticals, Inc. from 2003 to 2008, and as the Vice President & General Counsel at Primaryimmune Services, Inc. Mr. Bablak received his undergraduate degree from Allegheny College and his graduate degree from the University of Pittsburgh Law School.
Cargos activos de Jason Bablak
| Empresas | Cargo | Inicio |
|---|---|---|
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Director de Operaciones | - |
Antiguos cargos conocidos de Jason Bablak.
| Empresas | Cargo | Fin |
|---|---|---|
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Consejero General | - |
| Immune Deficiency Foundation | Consejero General | 01/01/2003 |
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Consejero General | 01/01/2000 |
| Popham Haik, Schnobrich & Kaufman Ltd. | Corporate Officer/Principal | 01/01/1995 |
Thar Pharmaceuticals, Inc.
 Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | Consejero General | - |
Formación de Jason Bablak.
| Allegheny College | Undergraduate Degree |
| University of Pittsburgh Law School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Health Technology |
| Immune Deficiency Foundation | Miscellaneous |
| Primaryimmune Services, Inc. | |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Commercial Services |
| Popham Haik, Schnobrich & Kaufman Ltd. | |
Thar Pharmaceuticals, Inc.
Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | Health Technology |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- Jason Bablak
